Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.
about
High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosisAllelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistanceDiagnostic accuracy of a molecular drug susceptibility testing method for the antituberculosis drug ethambutol: a systematic review and meta-analysisDevelopment of a quantitative assay for mycobacterial endogenous arabinase and ensuing studies of arabinase levels and arabinan metabolism in Mycobacterium smegmatisSignificance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates.Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from ChinaCharacteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, ChinaMolecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France.Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosisMutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis.Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis.Association between embB Codon 306 Mutations, Phenotypic Resistance Profiles, and Genotypic Characterization in Clinical Mycobacterium tuberculosis Isolates from Hebei, ChinaArabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets.Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand.Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China.Evaluation of the genotype MTBDRsl test for detection of second-line drug resistance in drug-resistant Mycobacterium tuberculosis strains in Myanmar.embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutationA Chip for Detecting Tuberculosis Drug Resistance Based on Polymerase Chain Reaction (PCR)-Magnetic Bead Molecule Platform
P2860
Q28481039-38EBB832-BB02-4BFC-9E62-A254D3C216FEQ33559021-20FCDB1A-9872-45B8-B385-65457239D977Q33935393-EB61F5CF-7BA4-4516-9E4F-9BE092883AE5Q34058789-754EE79A-D121-420E-B9CA-B44C381530DEQ34570395-0A9153C2-32D5-45DF-B732-1306EC48490FQ34648682-A1043622-0075-4FE1-B8F0-B605B285F074Q35168964-6A83C9DE-39C3-4B31-8404-B3741747C399Q35210458-CD54783A-D9A5-4FD7-B5E4-A993A0E59986Q35859945-02A56A43-690C-4631-BE3A-7FAFBC284679Q35879046-706DB749-5DD1-40F7-B75B-4CFA99EC313DQ35960725-66E614AB-67D8-496A-9563-BBA93EC75813Q36017031-BA9D7888-736F-4D79-94D3-D7C6EF260D8BQ37115785-1B1FC6A8-8049-4950-B8ED-50144DC05399Q37392900-12463EC5-44C2-44BB-AF0B-3462CBFA62A8Q37428663-FFA00FDD-EE41-4A7D-A2F7-E07AE351B226Q37970706-7F078522-9963-4900-B9A0-75781D11AB96Q38898564-78CE591C-EC03-4118-B4C1-69B56ED0D099Q41824901-34A862D6-2A03-4DEF-9642-8952A9184C6BQ41913299-B4E6B337-BACF-4D0B-81D1-0E0E3130D58CQ42146421-2CF32415-8038-49D6-9631-15458FD0990BQ47587138-44BBAD97-3357-4A6F-8BCD-0A13249ED937Q48251112-449CB2BA-E9E5-4EB8-AD89-E775ED69C264Q58485197-E30EA16D-3AC7-4058-A85E-CD231E80CCF3Q58758661-26B66D48-BAD8-4A88-BA41-6F2AB09E93F0
P2860
Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Novel mutations within the emb ...... of Mycobacterium tuberculosis.
@en
Novel mutations within the emb ...... of Mycobacterium tuberculosis.
@nl
type
label
Novel mutations within the emb ...... of Mycobacterium tuberculosis.
@en
Novel mutations within the emb ...... of Mycobacterium tuberculosis.
@nl
prefLabel
Novel mutations within the emb ...... of Mycobacterium tuberculosis.
@en
Novel mutations within the emb ...... of Mycobacterium tuberculosis.
@nl
P2093
P2860
P1476
Novel mutations within the emb ...... of Mycobacterium tuberculosis.
@en
P2093
Ann S G Lee
Sin Yew Wong
Siti Noor Khadijah Othman
P2860
P304
P356
10.1128/AAC.48.11.4447-4449.2004
P407
P577
2004-11-01T00:00:00Z